Clinical characteristics and manifestations in older patients with COVID-19

Chenchen Wei1, Ya Liu2, Yapeng Liu1

  • 1The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.

BMC Geriatrics
|October 9, 2020
PubMed

Insights

Older adults, particularly the oldest-old, face severe COVID-19 outcomes including organ damage and higher mortality. Key predictors of death in this group include age, lymphopenia, acute respiratory distress syndrome, and cardiac injury.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) disproportionately affects older adults.
  • Understanding the specific clinical profiles of elderly COVID-19 patients is crucial for targeted interventions.

Purpose of the Study:

  • To investigate the clinical characteristics, manifestations, and outcomes of older patients diagnosed with COVID-19.
  • To identify risk factors associated with mortality in elderly COVID-19 patients.

Main Methods:

  • A retrospective study analyzing data from 566 confirmed COVID-19 patients.
  • Collection and analysis of clinical characteristics, laboratory findings, complications, and outcome data.

Main Results:

  • Older patients (≥60 years) exhibited more comorbidities and laboratory abnormalities compared to younger groups.
  • Higher rates of acute respiratory distress syndrome (ARDS), acute cardiac injury, and heart failure were observed in older patients.
  • Mortality was significantly higher in older patients (18.6%) compared to younger and middle-aged groups.

Conclusions:

  • Older adults, especially the oldest-old, are at increased risk for severe systemic inflammation, multi-organ damage, and mortality from COVID-19.
  • Advanced age, lymphopenia, ARDS, acute cardiac injury, heart failure, and skeletal muscle injury are independent predictors of death in older COVID-19 patients.
  • Glucocorticoid use requires careful consideration in elderly COVID-19 patients due to potential harm.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.1K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
332
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
210
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
111
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
231